Live preview mode. Wire is not yet published.
Macquarie: market has oversold Resmed (RMD) as results came in lower that analyst expectations
Macquarie: market has oversold Resmed (RMD) as results came in lower that analyst expectations. We think underlying market demand remains strong and comp bidding-related headwinds will dissipate considerably in the coming months. Outperform.
Never miss an update
Enjoy this wire? Hit the ‘like’ button to let us know.
Stay up to date with my current content by
following me below and you’ll be notified every time I post a wire
Tom McKay is the Co-Founder and Managing Director of Livewire. Tom's passionate about democratising access to high quality investment ideas and insights, so all investors can make more informed and successful investment decisions.
Comments
Comments
Sign In or Join Free to comment